Latest fund size
$410M
Announced
September 12, 2026
Global HQ
United States
Members only
Check size
$5M-$20M
Members only
Stage focus
Seed, Series A, Growth
Members only
Regions of investment
United States
Members only
Luma Group is a New York-based multistage biotechnology investment firm founded in 2023 by Joshua Fink, bringing together scientific insight and computation to identify and back breakthrough life sciences companies from discovery through commercialization.
Themasap Khan — Co-Founder & Partner
themasap@lumagroup.com
Jamie Kasuboski — Partner & Head of Research
jamie@lumagroup.com
Negin Mokhtari — Venture Partner
negin.mokhtari@lumagroup.com
Members only
Names, roles, emails and LinkedIn profiles for the team, plus the fund's website.
Luma Group invests across the life sciences ecosystem globally, backing biotechnology companies translating breakthrough science into therapies, diagnostics, and medical devices.
The firm's thesis centers on the convergence of biology, chemistry, physics, and artificial intelligence reshaping medicine, supported by LABI, its proprietary AI system for data analysis and breakthrough validation. Luma invests from early-stage discovery through commercialization.
Members only
What the fund looks for in founders and which sectors it backs.
Luma Group closed its debut fund, LumaBio Fund I, at $410M in committed capital, structured as a 15-year investment vehicle.
LPs include a global investor base of financial institutions, sovereign wealth funds, insurance companies, family offices, and ultra-high-net-worth individuals.
The fund has already recorded its first exit, with portfolio company Vaccine Company acquired by Eli Lilly for up to $1.55B.
Members only
Fund size, LPs and track record.
Leadership
Investment Strategy
Check size of $5M–$20M.
The firm invests from early-stage discovery through commercialization, combining first-principles science partnerships with hands-on industry leadership support and its proprietary AI platform, LABI.
Notable Investments
Members only
Leadership, investment strategy, notable investments and exits.
